TB in children: still a real problem? Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012
The European union standards for tuberculosis care: Do they need an update? Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014
Pulmonary illness related to e-cigarette: a new epidemic in the US? Source: International Congress 2019 – Vaping-induced lung disease: what the respiratory health-care provider needs to know? Year: 2019
Tuberculosis elimination: a dream or a reality? The case of Oman Source: Eur Respir J, 51 (1) 1702027; 10.1183/13993003.02027-2017 Year: 2018
Tuberculosis elimination: dream or reality? The case of Cyprus Source: Eur Respir J 2014; 44: 543-546 Year: 2014
Abdominal TB – a rising issue? Source: Annual Congress 2007 - Epidemiology of tuberculosis II Year: 2007
Should we treat every patient with latent TB? Is there a cost to pay? Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018
Do we need to screen for latent TB when initiating a methotrexate treatment? Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment Year: 2013
Is there a need for prolonged follow up in mono-drug resistant TB? Source: International Congress 2014 – Tuberculosis: epidemiology and public health Year: 2014
Liver injury in treatment of latent tuberculosis infection - is the age cut-off for treatment justified? Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014
Tuberculosis situation and control in Europe: where are we and what to do next? Source: Eur Respir J 2005; 26: Suppl. 49, 476s Year: 2005
Drug resistant tuberculosis: is it enough to justify low treatment success in Russia? Source: Eur Respir J 2001; 18: Suppl. 33, 175s Year: 2001
Patients' perception of peakflowmeters use in Ukraine: does it pose an issue for asthma control? Source: Eur Respir J 2002; 20: Suppl. 38, 540s Year: 2002
Treating asthma in developing countries: is this a question of money? Source: Eur Respir J 2005; 26: Suppl. 49, 274s Year: 2005
Patients over 35 years experience more side-effects during latent TB treatment: Experience from an urban hospital with a high incidence of Tuberculosis Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Tuberculosis and intravenous drug users, impact of proximity measures in screening and treatment Source: International Congress 2015 – Screening strategies in TB Year: 2015
Old surgical techniques used nowadays in MDR-TB; going back to pre-antibiotic era? Source: Eur Respir J 2001; 18: Suppl. 33, 470s Year: 2001
Tuberculosis elimination, patients' lives and rational use of new drugs: revisited Source: Eur Respir J 2016; 47: 664-667 Year: 2016
Digital health technology for the end TB strategy: Developing priority products and making them work Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Doctors‘ compliance and adherence to treatment standards for asthma in Ukraine: who needs it more? Source: Eur Respir J 2005; 26: Suppl. 49, 381s Year: 2005